Viewing Study NCT03316560


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-06-18 @ 3:29 PM
Study NCT ID: NCT03316560
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-20
First Post: 2017-10-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
Sponsor: Beacon Therapeutics
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-04-16
Start Date Type: ACTUAL
Primary Completion Date: 2023-11-09
Primary Completion Date Type: ACTUAL
Completion Date: 2025-03
Completion Date Type: ESTIMATED
First Submit Date: 2017-10-10
First Submit QC Date: None
Study First Post Date: 2017-10-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2024-02-20
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2024-05-16
Last Update Post Date: 2024-05-20
Last Update Post Date Type: ACTUAL